Abstract
Differential treatment patterns by race for mental health services for individuals with schizophrenia (SCZ), including disparities in antipsychotic prescription patterns, have been reported. This study assessed differences in utilization of first generation (FG) vs second generation (SG) long-acting injectable antipsychotics (LAIs) between Black and White Medicaid enrollees with SCZ and examined factors associated with FG vs SG LAI initiation, including race.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
